2023³â ¼¿ï¾Æ»êº´¿ø ¾Ï ½ÉÆ÷Áö¾ö : 2023-09-01
±³À°ÀÏÀÚ : 2023-09-01
±³À°Àå¼Ò : ¼¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ ´ë°´ç
±³À°ÁÖÁ¦ : 2023³â ¼¿ï¾Æ»êº´¿ø ¾Ï ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ¼¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ÇãÁ¤ÀÎ
¿¬¶ôó : 02-3010-2653
À̸ÞÀÏ : hji0929@amc.seoul.kr
±³À°Á¾·ù : ¹æ»ç¼±Á¾¾çÇаú
Âü¼®¿¹»óÀÎ : 700¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 09:00~09:05 °³È¸»ç ¼Û½Ã¿(¼¿ï¾Æ»êº´¿ø ¾Ïº´¿ø)
±âŸ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 09:05~09:10 Welcome Remark ¼Û½Ã¿(¼¿ï¾Æ»êº´¿ø ¾Ïº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 09:10~09:40 Moving Forward with Precision Oncology in Breast Cancer Prue Francis(Peter MacCallum Cancer Center)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 09:40~10:10 PARPi, ADCs, and Other Targets in Epithelial Ovarian Cancer Angeles Alvarez Secord(Duke Cancer Institute)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 10:10~10:40 Carbon-ion Radiotherapy; the Past, Present, and Furture Hitoshi Ishikawa(QST Hospital)
ÈÞ½Ä 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 10:40~10:55 Coffee Break ±èÅ¿ø(¼¿ï¾Æ»êº´¿ø ¾Ïº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 10:55~11:25 Digital Innovation and Compliance in Precision Oncology ±è±ÔÇ¥(¼¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 11:25~11:55 ÃÊ°Å´ë AI½Ã´ë ¿ì¸®ÀÇ ´ëÀÀÀü·«°ú ÀÇ·áºÐ¾ßÀÇ ¿µÇâ ÇÏÁ¤¿ì(³×À̹ö AI·¦)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 11:55~12:25 Oncology Future Market Trend : Will the new technologies and platforms be magic bullets? Á¤¼ö¿ë(IQVIA)
½Ä»ç 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 12:30~14:00 Luncheon Áö¿øÁØ(¼¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 14:00~14:20 Advances of Bronchoscopic Techniques for the Diagnosis and Treatment of Early Stage Lung Cancer Áö¿øÁØ(¼¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 14:20~14:40 Updates in Patient Selection and Oncological Outcome for Sublobar Resection in Early-stage NSCLC À±À籤(¼¿ï¾Æ»êº´¿ø ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 14:40~15:00 Optimal Stereotactic Ablative Radiotherapy for Early-stage Lung Cancer ¼Û½Ã¿(¼¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú)
Åä·Ð 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 15:00~15:10 Q&A ¼Û½Ã¿(¼¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú)
ÈÞ½Ä 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 15:10~15:20 Coffee Break À±½Å±³(¼¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 15:20~15:40 Perioperative Immunotherapy for NSCLC in Daily Practice, Experience of ASAN À±½Å±³(¼¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 15:40~16:00 Essentials for Radiologic Tumor Assessment in lung Cancer Treated with Neoadjuvant Immuno-chemotherapy ÃÖÁÖ¾Ö(¼¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)
±³À°½Ã°£ 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 16:00~16:20 Pathologic Assessment of Lung Cancer Resection Specimens Following Neoadjuvant therapy ȲÈñ»ó(¼¿ï¾Æ»êº´¿ø º´¸®°ú)
Åä·Ð 09¿ù 01ÀÏ µ¿°ü 6Ãþ ´ë°´ç 16:20~16:30 Q&A ȲÈñ»ó(¼¿ï¾Æ»êº´¿ø º´¸®°ú)